BFR for Hip Injury

UCHealth Steadman Hawkins Clinic Denver, Englewood, CO
Hip InjuryBFR - Device
Eligibility
14 - 70
All Sexes

Study Summary

This trial will investigate whether blood flow restriction therapy can help with post-operative rehabilitation following hip arthroscopy. The cuffs will be added to the current SOC for hip scope PT for the intervention group.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Fisetin
1
Healthy Individuals
1
SuperPATH

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: 2 Years

2 Years
Brief Resiliency Score
Hip extensor strength
LEFS
PROMIS pain
PROMIS physical function
Tegner Activity Scale
additional hip musculature strength
i-HOT
range of motion (ROM)
single leg squat test

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Fisetin
1
Healthy Individuals
1
SuperPATH

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

SOC Group
1 of 2
BFR Group
1 of 2

Active Control

Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: BFR · No Placebo Group · N/A

BFR Group
Device
Experimental Group · 1 Intervention: BFR · Intervention Types: Device
SOC GroupNoIntervention Group · 1 Intervention: SOC Group · Intervention Types:
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BFR
2019
N/A
~30

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,644 Previous Clinical Trials
1,660,921 Total Patients Enrolled
James Genuario, MDPrincipal InvestigatorUniversity of Colorado SOM
3 Previous Clinical Trials
89 Total Patients Enrolled

Eligibility Criteria

Age 14 - 70 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Does the protocol for this research encompass individuals of a young age?

"This medical trial has outlined eligibility requirements of being between the ages of 14 and 70. There are additional studies tailored to those under 18 and over 65, both with a total participant count of 7 and 2 respectively." - Anonymous Online Contributor

Unverified Answer

Is this experiment actively recruiting participants currently?

"That is accurate. According to clinicaltrials.gov, this research project – that was initially posted on April 29th 2022 – seeks participants and has recently been updated . The goal is to enroll 120 patients from a single location." - Anonymous Online Contributor

Unverified Answer

How can I become enrolled in this experiment?

"This medical trial requires that prospective participants are aged between 14 and 70 years old, with hip injuries. Altogether, 120 individuals will be enrolled in the study." - Anonymous Online Contributor

Unverified Answer

How large is the patient cohort enrolled in this experiment?

"Affirmative. Information hosted on clinicaltrials.gov implies that this research endeavour, first published on April 29th 2022, is currently recruiting test subjects. In order to meet their quota of 120 patients, they need volunteers from 1 distinct medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top